| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Second Regular National Report on the Implementation of the Cartagena Protocol on Biosafety
Record information and status
Record ID
102414
Status
Published
Date of creation
2011-09-30 22:00 UTC (diversidadbiologicaven.dg@gmail.com)
Date of publication
2011-09-30 22:00 UTC (diversidadbiologicaven.dg@gmail.com)

This document is also available in the following languages:
Origin of report
Country
  • Venezuela (Bolivarian Republic of)
Contact officer for report
Coordinates
Dr. Jesús Manzanilla Puppo
Director General de la Oficina Nacional de Diversidad Biológica
Ministerio del Poder Popular para el Ambiente
Centro Simón Bolivar, Torre Sur, Piso 9, El Silencio, Caracas, Distrito Capital
Caracas, Distrito Capital, Distrito Capital
Venezuela (Bolivarian Republic of), 2101
Phone:0058 212-4084757
Fax:0058 212-408494
Email:jesusmanzanillap@hotmail.com
Consulted stakeholders
9. Organizations/stakeholders who were consulted or participated in the preparation of this report
ES
Direcciones Estadales Ambientales: Mérida, Monagas, Capital y Miranda.  Nivel Central del Ministerio del Poder Popular para el Ambiente (Consultoría Jurídica, Oficina Administrativa de Permisiones y la Oficina Nacional de Diversidad Biológica).
Universidad de los Andes. Facultad de Ciencias
Universidad Nacional Experimental del Táchira
Asociacion Mano a Mano
Instituto de Ciencias Ambientales y Ecológicas
Productores integrales del Paramo (PROINPA)
Universidad de Oriente
Instituto Nacional de Investigaciones Agrícolas (nucleos Mérida y Monagas)
Instituto Nacional de Sanidad Agrícola Integral. Ministerio del Poder Popular para la Agricultura y Tierras
Red de accion para AMeica Latina Libre de Transgenicos RePAL-Ve
Instituto Nacional de Parques (Región Oriental)
Comisión de Ambiente, Alcaldía de Maturín
FUNDACITE- Monagas
Universidad Gran Mariscal de Ayacucho
Universidad Bolivariana de Venezuela (Núcleo Maturín)
Ministerio del Poder Popular para la Salud
Universidad Pedagógica Experimental Libertador (nucleo Monagas)
Instituto de Estudios Avanzados. Ministerio del Poder Popular para la Ciencia y la Tecnología e Industrias Intermedias
Ministerio del Poder Popular para la Alimentación
Universidad Simón Rodríguez
Ministerio del Poder Popular para las Relaciones Exteriores. Despacho para África
Submission
10. Date of submission
2011-09-30
11. Time period covered by this report
Start date
2008-09-01
Time period covered by this report
End date
2011-09-30
Party to the Cartagena Protocol on Biosafety
12. Is your country a Party to the Cartagena Protocol on Biosafety (CPB)?
  • Yes
Article 2 – General provisions
15. Has your country introduced the necessary legal, administrative and other measures for the implementation of the Protocol?
  • A domestic regulatory framework is partially in place
16. Which specific instruments are in place for the implementation of your national biosafety framework?
  • One or more national biosafety laws
17. Has your country established a mechanism for the budgetary allocations of funds for the operation of its national biosafety framework?
  • Yes
18. Does your country have permanent staff to administer functions directly related to the national biosafety framework?
  • Yes
19. If you answered Yes to question 18, how many permanent staff members are in place whose functions are directly related to the national biosafety framework?
  • Less than 10
20. Has your country’s biosafety framework / laws / regulations / guidelines been submitted to the Biosafety Clearing-House (BCH)?
  • Yes
21. Here you may provide further details on the implementation of Article 2 in your country:
ES
La medida más importante tomada durante este trienio fue la construcción colectiva de la Estrategia Nacional de Conservación de la Diversidad Biólogica 2010-2020, que se realizó con la participación simultánea de amplios sectores de la sociedad  (académicos, servidores públicos, aficionados y organizaciones sociales de base),en numerosos talleres llevados a cabo durante 18 meses,los cuales permitieron la participación de más de 1600 personas a nivel nacional, promoviendo el debate y enriqueciendo el diagnóstico con diferentes puntos de vista. En esta etapa se identificaron los problemas de la pérdida de Diversidad Biológica para luego analizarlos en sus causas y consecuencias. Las causas identificadas fueron agrupadas en 3 diferentes escalas: próximas, intermedias y estructurales. La etapa siguiente al diagnóstico consistió en construir colectivamente estrategias para conservar la Diversidad Biológica. Partiendo del diagnóstico de los problemas y de la situación actual, se construyeron 7 líneas estratégicas, como elementos técnicos para abordar la situación actual de la pérdida de Diversidad Biológica y 7 ejes transversales como elementos políticos y sociales necesarios para garantizar la conservación con compromiso social, con una línea para el control y fiscalización de organismos modificados genéticamente.  Este aporte generado desde la Oficina Nacional de Diversidad Biológica, es una potente herramienta legal para promover la soberanía alimentaría de nuestro país y la suprema felicidad social perdurable del colectivo venezolano. Hay parcialmente establecido un marco jurídico y administrativo, para articular las acciones y mandatos establecidos en el Protocolo de Cartagena (PCB). Aún cuando la Ley de Gestión sobre la Diversidad Biológica establece un capítulo específico para la bioseguridad, se requiere de un Reglamento Parcial que permita regular y controlar las actividades con OVM, para así implementar la Ley.Además contamos con: Decreto sobre Organización y funcionamiento de la Comisión Nacional de Bioseguridad (G.O. 39.293 del 08/10/2009), la Ley de Semillas, Materiales para la Reproducción Animal e Insumos Biológicos (2002), además de la Ley de Salud Agrícola Integral (2000), y la Ley de Salud Ambiental (2011), por mencionar algunos documentos jurídicos que regulan de manera indirecta la aplicación del Protocolo. Aún así, se debe, afinar las bases normativas, estableciendo claras directrices técnicas y metodológicas,diseñando procesos administrativos, generando información fidedigna, y muy particularmente desarrollando la capacidad para tomar posición y decisiones de país en materia de OVM. Es necesario contar con una Comisión Nacional de Bioseguridad plenamente instalada, capacitada, y continuar con la formación de recursos humanos y de infraestructura, principalmente para la identificación, evaluación y manejo de los posibles riesgos de los OVM. Con miras a iniciar un Sistema Nacional de Bioseguridad en el país, varios Ministerios han tomado medidas para instalar capacidades institucionales en pos de la bioseguridad. El Ministerio del Ambiente, como autoridad competente y coordinadora de los demás Ministerios, ha capacitado su personal en el área de bioseguridad, y recientemente en el manejo del CIISB, y ha finalizado la construcción de un Laboratorio de Referencia para la detección de OVM. No obstante, los pasos más significativos los ha dado el Ministerio de Ciencia y Tecnología, a través del Instituto de Estudios Avanzados (IDEA), que cuenta con un laboratorio, de pequeñas dimensiones, de trazabilidad de OVM que fungirá para la capacitación de personal de todos los Ministerios con competencia. Adicionalmente ha iniciado también la construcción de un Centro de Agrobiotecnología, lo que demuestra la importancia otorgada por el país al desarrollo biotecnológico y científico como herramienta de crecimiento. Estas iniciativas han provisto al país de valiosas capacidades técnicas y tecnológicas, incluida infraestructura, con las que cuenta ahora para la aplicación del PCB. Aún así, se debe continuar instalando capacidades en otros Ministerios con potestades en bioseguridad y llegar al entramado institucional ideal para establecer los mecanismos y hacer cumplir las funciones señaladas en el PCB.
Article 5 – Pharmaceuticals
22. Does your country regulate the transboundary movement, handling and use of living modified organisms (LMOs) which are pharmaceuticals?
  • No
24. Here you may provide further details on the implementation of Article 5 in your country:
ES
En la República Bolivariana de Venezuela no existe ninguna reglamentación específica para regular el movimiento transfronterizo, la manipulación y la utilización de OVM que son productos farmacéuticos. Sin embargo, existen algunas leyes que tratan de manera indirectamente las regulaciones y procedimiento de evaluación de OVM destinados a uso como fármacos. No obstante, el registro de medicamentos biotecnológicos que involucra transformación genética se encuentra amparado en la Ley de Medicamentos del 2000 y en las Normas especifícas desarrolladas por el Instituto Nacional de Higiene Rafael Rangel del Ministerio del Poder Popular para la Salud.
Article 6 – Transit and Contained use
25. Does your country regulate the transit of LMOs?
  • No
26. Does your country regulate the contained use of LMOs?
  • No
28. Here you may provide further details on the implementation of Article 6 in your country:
ES
En la República Bolivariana de Venezuela no existe ninguna reglamentación específica para regular el movimiento transfronterizo, la manipulación y la utilización de OVM que son productos farmacéuticos. Sin embargo, existen algunas leyes que tratan de manera indirecta las regulaciones y procedimiento de evaluación de OVM destinados a uso como fármacos.
Articles 7 to 10 – Advance Informed Agreement (AIA) and intentional introduction of LMOs into the environment
29. Has your country adopted law(s) / regulations / administrative measures for the operation of the AIA procedure of the Protocol?
  • No
30. Has your country adopted a domestic regulatory framework consistent with the Protocol regarding the transboundary movement of LMOs for intentional introduction into the environment?
  • No
31. Has your country established a mechanism for taking decisions regarding first intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
33. Has your country established a mechanism for monitoring potential effects of LMOs that are released into the environment?
  • No
34. Does your country have the capacity to detect and identify LMOs?
  • Yes, to some extent
35. Has your country established legal requirements for exporters under its jurisdiction to notify in writing the competent national authority of the Party of import prior to the intentional transboundary movement of an LMO that falls within the scope of the AIA procedure?
  • No
36. Has your country established legal requirements for the accuracy of information contained in the notification?
  • No
37. Has your country ever received an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • No
38. Has your country ever taken a decision on an application / notification regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • Not applicable
39. If you answered Yes to question 38, how many LMOs has your country approved to date for import for intentional introduction into the environment?
  • Not applicable
40. If you answered Yes to question 38, how many LMOs, not imported, has your country approved to date for intentional introduction into the environment?
  • Not applicable
41. In the current reporting period, how many applications/notifications has your country received regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
42. In the current reporting period, how many decisions has your country taken regarding intentional transboundary movements of LMOs for intentional introduction into the environment?
  • None
50. Here you may provide further details on the implementation of Articles 7-10 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs for intentional introduction to the environment:
ES
En el país sólo existe un laboratorio capaz de detectar e identificar OVM cumpliendo con los estándares establecidos a nivel internacional. Por tanto, se hace necesario crear y reforzar otros laboratorios capaces de cubrir las actividades de detección e identificación de OVM. Adicionalmente, se necesita la creación de redes de laboratorio interconectadas a nivel nacional e internacional para cumplir con este aparte.
Article 11 – Procedure for living modified organisms intended for direct use as food or feed, or for processing (LMOs-FFP)
51. Has your country adopted specific law(s) or regulation(s) for decision-making regarding domestic use, including placing on the market, of LMOs-FFP?
  • No
52. Has your country established legal requirements for the accuracy of information to be provided by the applicant?
  • No
53. Has your country established a mechanism to ensure that decisions regarding LMOs-FFP that may be subject to transboundary movement will be communicated to the Parties through the BCH?
  • Yes
54. Has your country established a mechanism for taking decisions on the import of LMOs-FFP?
  • No
55. Has your country declared through the BCH that in the absence of a regulatory framework its decisions prior to the first import of an LMO-FFP will be taken according to Article 11.6 of the Cartagena Protocol on Biosafety?
  • No
56. Has your country indicated its needs for financial and technical assistance and capacity building in respect of LMOs-FFP?
  • Yes
57. Has your country ever taken a decision on LMOs-FFP (either on import or domestic use)?
  • No
63. Here you may provide further details on the implementation of Article 11 in your country, including measures in case of lack of scientific certainty on potential adverse effects of LMOs-FFP:
ES
El país posee reglamentaciones aplicables de manera indirecta a OVM destinados para uso directo como alimento humano, animal o para procesamiento.
En cuanto a los requisitos legales respecto a la precisión de la información proporcionada por el solicitante, el país ha adaptado los mecanismos desarrollados en el Protocolo de Cartagena.
Se sugiere que el país desarrolle un listado donde se concreten e identifiquen las necesidades de asistencia financiera y técnica, y de creación de capacidad respecto a los OVM destinados para uso directo como alimento humano, animal o para procesamiento. Es importante que las acciones  a emprender para el cumplimiento del tal mandato puedan ser accionadas tanto nacional como internacionalmente, y que las mismas se caractericen por ser eficaces y eficientes, tomando en consideración las necesidades de talento humano, en materia de análisis y gestión de riesgos, ambiental, sociales, culturales y económicas, entre otras.
Article 12 – Review of decision
64. Has your country established a mechanism for the review and change of a decision regarding an intentional transboundary movement of LMOs?
  • No
65. Has your country ever received a request for a review of a decision?
  • No
66. Has your country ever reviewed / changed a decision regarding an intentional transboundary movement of LMOs?
  • No
67. In the current reporting period, how many decisions were reviewed and/or changed regarding an intentional transboundary movement of an LMO?
  • None
Article 13 – Simplified procedure
72. Has your country established a system for the application of the simplified procedure regarding an intentional transboundary movement of LMOs?
  • No
73. Has your country ever applied the simplified procedure?
  • No
75. In the current reporting period, how many LMOs has your country applied the simplified procedure to?
  • None
Article 14 – Bilateral, regional and multilateral agreements and arrangements
77. Has your country entered into any bilateral, regional or multilateral agreements or arrangements?
  • Yes
78. If you answered Yes to question 77, has your country informed the Parties through the BCH of the agreements or arrangements?
  • No
79. If you answered Yes to question 77, please provide a brief description of the scope and objective of the agreements or arrangements entered into:
ES
Alcance: Establecer las normas de funcionamiento del Instituto Nacional de Investigaciones Agrícolas (INIA) del Ministerio del Poder Popular para la Agricultura y Tierras y cuyo objetivo es estrablecer el reglamento de funcionamiento en bioseguridad del INIA.
Article 15 – Risk assessment
81. Has your country established a mechanism for conducting risk assessments prior to taking decisions regarding LMOs?
  • No
83. Has your country established guidelines for how to conduct risk assessments prior to taking decisions regarding LMOs?
  • No
84. Has your country acquired the necessary domestic capacity to conduct risk assessment?
  • No
85. Has your country established a mechanism for training national experts to conduct risk assessments?
  • No
86. Has your country ever conducted a risk assessment of an LMO for intentional introduction into the environment?
  • No
87. Has your country ever conducted a risk assessment of an LMO intended for direct use as food or feed, or for processing?
  • No
88. If your country has taken decision(s) on LMOs for intentional introduction into the environment or on domestic use of LMOs-FFP, were risk assessments conducted for all decisions taken?
  • Not applicable
89. Has your country submitted summary reports of the risk assessments to the BCH?
  • Not applicable
90. In the current reporting period, if your country has taken decisions regarding LMOs, how many risk assessments were conducted in the context of these decisions?
  • None
91. Has your country ever required the exporter to conduct the risk assessment(s)?
  • Not applicable
92. Has your country ever required the notifier to bear the cost of the risk assessment(s) of LMOs?
  • Not applicable
93. Here you may provide further details on the implementation of Article 15 in your country:
ES
Se han efectuado esfuerzos aislados en la capacitación de talento humano capaz de realizar evaluaciones de riesgos de OVM.
Article 16 – Risk management
94. Has your country established and maintained appropriate and operational mechanisms, measures and strategies to regulate, manage and control risks identified in risk assessments for:
94.1) LMOs for intentional introduction into the environment?
  • No
94.2) LMOs intended for direct use as food or feed, or for processing?
  • No
95. Has your country established and maintained appropriate measures to prevent unintentional transboundary movements of LMOs?
  • No
96. Has your country taken measures to ensure that any LMO, whether imported or locally developed, undergoes an appropriate period of observation that is commensurate with its life-cycle or generation time before it is put to its intended use?
  • No
97. Has your country cooperated with other Parties with a view to identifying LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • Yes
98. Has your country cooperated with other Parties with a view to taking measures regarding the treatment of LMOs or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity?
  • No
99. Here you may provide further details on the implementation of Article 16 in your country, including any details regarding risk management strategies, also in case of lack of scientific certainty on potential adverse effects of LMOs:
ES
El país no cuenta con un sistema específico de gestión de riesgos de OVM. Sin embargo, ha cooperado con otros países parte y no parte en la capacitación de talento humano para la aplicación de mecanismos, medidas y estrategias relacionadas con la regulación, gestión y control de OVM que pudieran tener efectos adversos para la conservación y la utilización sostenible de la diversidad biológica venezolana. Adicionalmente, se cuenta con instituciones como el Instituto Nacional de Sanidad Agrícola Integral presente en todas las aduanas del país, así como con funcionarios de la guardería ambiental apostados en las mismas, las cuales poseen mecanismos y estrategias para la toma de decisiones relacionadas con el movimiento  transfronterizo de OVM. Por ello, la importancia de aplicar a los fondos para implementar el marco nacional de bioseguridad en Venezuela.
Article 17 – Unintentional transboundary movements and emergency measures
100. Has your country made available to the BCH the relevant details setting out its point of contact for the purposes of receiving notifications under Article 17?
  • Yes
101. Has your country established a mechanism for addressing emergency measures in case of unintentional transboundary movements of LMOs that are likely to have significant adverse effect on biological diversity?
  • No
102. Has your country implemented emergency measures in response to information about releases that led, or may have led, to unintentional transboundary movements of LMOs?
  • No
103. In the current reporting period, how many times has your country received information concerning occurrences that led, or may have led, to unintentional transboundary movement(s) of one or more LMOs to or from territories under its jurisdiction?
  • Never
107. Here you may provide further details on the implementation of Article 17 in your country:
ES
No se tiene información verificada, pero existen sospechas sobre situaciones que conduzcan o que puedan conducir a movimientos transfronterizos involuntarios de uno o más OVM hacia o desde territorios bajo la jurisdicción nacional
Article 18 – Handling, transport, packaging and identification
108. Has your country taken measures to require that LMOs that are subject to transboundary movement are handled, packaged and transported under conditions of safety, taking into account relevant international rules and standards?
  • No
109. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is not known through means such as identity preservation systems, they may contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
110. Has your country taken measures to require that documentation accompanying LMOs-FFP clearly identifies that, in cases where the identity of the LMOs is known through means such as identity preservation systems, they contain living modified organisms and are not intended for intentional introduction into the environment, as well as a contact point for further information?
  • No
111. Has your country taken measures to require that documentation accompanying LMOs that are destined for contained use clearly identifies them as living modified organisms and specifies any requirements for the safe handling, storage, transport and use, the contact point for further information, including the name and address of the individual and institution to whom the LMO are consigned?
  • No
112. Has your country taken measures to require that documentation accompanying LMOs that are intended for intentional introduction into the environment of the Party of import, clearly identifies them as living modified organisms; specifies the identity and relevant traits and/or characteristics, any requirements for the safe handling, storage, transport and use, the contact point for further information and, as appropriate, the name and address of the importer and exporter; and contains a declaration that the movement is in conformity with the requirements of this Protocol applicable to the exporter?
  • No
113. Does your country have the capacity to enforce the requirements of identification and documentation of LMOs?
  • Yes, to some extent
114. Has your country established procedures for the sampling and detection of LMOs?
  • Yes, to some extent
115. Here you may provide further details on the implementation of Article 18 in your country:
ES
En la República Bolivariana de Venezuela, existen instituciones capaces de hacer cumplir los requisitos de identificación, documentación, muestreo y detección de OVM, todo ello, adaptado a los requerimientos y estándares establecidos a nivel internacional. Sin embargo, se resaltan las deficiencias relacionadas con este aparte, ya que solo en el país se cuenta con un laboratorio capaz de suscribir tales actividades. Por tanto, se hace necesario crear y reforzar otros laboratorios capaces de cubrir las actividades de detección e identificación de OVM. Adicionalmente, se necesita la creación de redes de laboratorio interconectadas a nivel nacional e internacional para cumplir con este aparte.
Article 19 – Competent National Authorities and National Focal Points
116. Has your country designated one national focal point for the Cartagena Protocol to be responsible for liaison with the Secretariat?
  • Yes
117. Has your country designated one national focal point for the Biosafety Clearing-House to liaise with the Secretariat regarding issues of relevance to the development and implementation of the BCH?
  • Yes
118. Has your country designated one or more competent national authorities, which are responsible for performing the administrative functions required by the Cartagena Protocol on Biosafety and are authorized to act on your country’s behalf with respect to those functions?
  • Yes, one
120. Has your country made available the required information referred in questions 116-119 to the BCH?
  • Yes, all information
122. Has your country established adequate institutional capacity to enable the competent national authority(ies) to perform the administrative functions required by the Cartagena Protocol on Biosafety?
  • Yes, to some extent
Article 20 – Information Sharing and the Biosafety Clearing-House (BCH)
124. Please provide an overview of the status of the information provided by your country to the BCH by specifying for each category of information whether it is available and whether it has been submitted to the BCH.
124.a) Existing national legislation, regulations and guidelines for implementing the Protocol, as well as information required by Parties for the advance informed agreement procedure (Article 20, paragraph 3 (a))
  • Information available and in the BCH
124.b) National laws, regulations and guidelines applicable to the import of LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 5)
  • Information not available
124.c) Bilateral, multilateral and regional agreements and arrangements (Articles 14, paragraph 2 and 20, paragraph 3 (b))
  • Information available but not in the BCH
124.d) Contact details for competent national authorities (Article 19, paragraphs 2 and 3), national focal points (Article 19, paragraphs 1 and 3), and emergency contacts (Article 17, paragraph 3 (e))
  • Information available and in the BCH
124.e) Reports submitted by the Parties on the operation of the Protocol (Article 20, paragraph 3 (e))
  • Information available and in the BCH
124.f) Decisions by a Party on regulating the transit of specific living modified organisms (LMOs) (Article 6, paragraph 1)
  • Information not available
124.g) Occurrence of unintentional transboundary movements that are likely to have significant adverse effects on biological diversity (Article 17, paragraph 1)
  • Information not available
124.h) Illegal transboundary movements of LMOs (Article 25, paragraph 3)
  • Information not available
124.i) Final decisions regarding the importation or release of LMOs (i.e. approval or prohibition, any conditions, requests for further information, extensions granted, reasons for decision) (Articles 10, paragraph 3 and 20, paragraph 3(d))
  • Information not available
124.j) Information on the application of domestic regulations to specific imports of LMOs (Article 14, paragraph 4)
  • Information not available
124.k) Final decisions regarding the domestic use of LMOs that may be subject to transboundary movement for direct use as food or feed, or for processing (Article 11, paragraph 1)
  • Information not available
124.l) Final decisions regarding the import of LMOs intended for direct use as food or feed, or for processing that are taken under domestic regulatory frameworks (Article 11, paragraph 4) or in accordance with annex III (Article 11, paragraph 6) (requirement of Article 20, paragraph 3(d))
  • Information not available
124.m) Declarations regarding the framework to be used for LMOs intended for direct use as food or feed, or for processing (Article 11, paragraph 6)
  • Information not available
124.n) Review and change of decisions regarding intentional transboundary movements of LMOs (Article 12, paragraph 1)
  • Information not available
124.o) LMOs granted exemption status by each Party (Article 13, paragraph 1)
  • Information not available
124.p) Cases where intentional transboundary movement may take place at the same time as the movement is notified to the Party of import (Article 13, paragraph 1)
  • Information not available
124.q) Summaries of risk assessments or environmental reviews of LMOs generated by regulatory processes and relevant information regarding products thereof (Article 20, paragraph 3 (c))
  • Information not available
125. Has your country established a mechanism for strengthening the capacity of the BCH National Focal Point to perform its administrative functions?
  • Yes
126. Has your country established a mechanism for the coordination among the BCH National Focal Point, the Cartagena Protocol focal point, and the competent national authority(ies) for making information available to the BCH?
  • Yes
127. Does your country use the information available in the BCH in its decision making processes on LMOs?
  • No
128. Has your country experienced difficulties accessing or using the BCH?
  • No
129. If you answered Yes to question 128, has your country reported these problems to the BCH or the Secretariat?
  • Not applicable
130. Is the information submitted by your country to the BCH complete and up-to date?
  • Yes
131. Here you may provide further details on the implementation of Article 20 in your country:
ES
Si se utiliza la información disponible en el CIISB más que para la adopción de decisiones sobre OVM es para tener referencias técnicas y científicas que puedan aportar elementos de bases para el conocimiento de la situación mundial de los movimientos transfronterizos de OVM.
Article 21 – Confidential information
132. Has your country established procedures to protect confidential information received under the Protocol?
  • Yes
133. Does your country allow the notifier to identify information that is to be treated as confidential?
  • In some cases only
134. Here you may provide further details on the implementation of Article 21 in your country:
ES
Se aclara que para el país existen dos niveles de niveles de confidencialidad para el tratado de la información, uno el que establece el Ministerio del Poder Popular para el Ambiente, como punto focal nacional de la aplicación del Protocolo de Cartagena sobre Seguridad de la Biotecnología, y el otro el relacionado con la información que debe ser discutida en el seno de la Comisión Nacional de Bioseguridad.
Article 22 – Capacity-building
135. Has your country received external support or benefited from collaborative activities with other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
136. If you answered Yes to question 135, how were these resources made available?
  • Multilateral channels
137. Has your country provided support to other Parties in the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
138. If you answered Yes to question 137, how were these resources made available?
  • Multilateral channels
139. Is your country eligible to receive funding from the Global Environment Facility (GEF)?
  • Yes
140. Has your country ever initiated a process to access GEF funds for building capacity in biosafety?
  • Yes
141. If you answered Yes to question 140, how would you characterize the process?
Please add further details about your experience in accessing GEF funds under question 150.
  • Easy
142. Has your country ever received funding from the GEF for building capacity in biosafety?
  • Development of national biosafety frameworks
  • Building Capacity for Effective Participation in the BCH (Phase I)
  • Building Capacity for Effective Participation in the BCH (Phase II)
143. During the current reporting period, has your country undertaken activities for the development and/or strengthening of human resources and institutional capacities in biosafety?
  • Yes
144. If you answered Yes to question 143, in which of the following areas were these activities undertaken?
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Identification of LMOs, including their detection
  • Scientific biosafety research relating to LMOs
145. During the current reporting period, has your country carried out a capacity-building needs assessment?
  • Yes
146. Does your country still have capacity-building needs?
  • Yes
147. If you answered Yes to question 146, indicate which of the following areas still need capacity-building.
  • Institutional capacity
  • Human resources capacity development and training
  • Risk assessment and other scientific and technical expertise
  • Risk management
  • Public awareness, participation and education in biosafety
  • Information exchange and data management including participation in the Biosafety Clearing-House
  • Scientific, technical and institutional collaboration at subregional, regional and international levels
  • Technology transfer
  • Identification of LMOs, including their detection
  • Socio-economic considerations
  • Implementation of the documentation requirements under Article 18.2 of the Protocol
  • Handling of confidential information
  • Measures to address unintentional and/or illegal transboundary movements of LMOs
  • Scientific biosafety research relating to LMOs
  • Taking into account risks to human health
  • consideraciones socio-culturales
148. Has your country developed a capacity-building strategy or action plan?
  • Yes
149. Has your country submitted the details of national biosafety experts to the Roster of Experts in the BCH?
  • No
150. Here you may provide further details on the implementation of Article 22 in your country, including further details about your experience in accessing GEF funds:
ES
La Estrategia Nacional para la Conservación de la Diversidad Biológica, de la República Bolivariana de Venezuela, es una potente herramienta desarrollada por el colectivo nacional, en donde se establecen una serie de líneas estratégicas y ejes transversales en materia de conservación de la diversidad biológica. En ella, se enmarca la educación para la conservación de la diversidad biológica, cuyo objetivo es promover el desarrollo de una conciencia crítica sobre la diversidad biológica mediante la difusión y la creación de espacios para el debate sobre su valor social, como patrimonio natural y recurso fundamental para desarrollo de la nación. Al respecto, la Oficina Nacional de Diversidad Biológica está abocada a diseñar programas y planes de acción para crear capacidades, con compromiso en materia de diversidad biológica, y muy especialmente en los temas relacionados con uso, manejo, transferencia y utilización segura de los OVM.
Article 23 – Public awareness and participation
151. Has your country established a strategy or put in place legislation for promoting and facilitating public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to some extent
152. Has your country established a biosafety website?
  • Yes
153. Has your country established a mechanism to ensure public access to information on living modified organisms that may be imported?
  • No
154. Has your country established a mechanism to consult the public in the decision-making process regarding LMOs?
  • No
155. Has your country established a mechanism to make available to the public the results of decisions taken on LMOs?
  • No
156. Has your country taken any initiative to inform its public about the means of public access to the Biosafety Clearing-House?
  • No
157. In the current reporting period, has your country promoted and facilitated public awareness, education and participation concerning the safe transfer, handling and use of LMOs?
  • Yes, to a limited extent
158. If you answered Yes to question 157, has your country cooperated with other States and international bodies?
  • Not applicable
159. In the current reporting period, how many times has your country consulted the public in the decision-making process regarding LMOs and made the results of such decisions available to the public?
  • None
160. Here you may provide further details on the implementation of Article 23 in your country:
ES
La Estrategia Nacional para la Conservación de la Diversidad Biológica, de la República Bolivariana de Venezuela, fomenta la sensibilización, educación y participación del colectivo en lo que atañe a la seguridad de la transferencia, manipulación y utilización biotecnología. Sin embargo, se hace necesario el diseño de estrategias más específicas por parte de todas las autoridades nacionales con competencia y las relacionadas con la educación y participación del público en la materia.
Por otra parte, a pesar de que no existe un sitio web específico, algunas plataformas institucionales nutren sus páginas con información acerca de los avances relacionados con seguridad de la biotecnología en el país.
Article 24 – Non-Parties
161. Has your country entered into any bilateral, regional, or multilateral agreement with non-Parties regarding transboundary movements of LMOs?
  • No
162. Has your country ever imported LMOs from a non-Party?
  • No
163. Has your country ever exported LMOs to a non-Party?
  • No
166. If your country is not a Party to the Cartagena Protocol, has it contributed information to the BCH on LMOs released in, or moved into, or out of, areas within its national jurisdiction?
  • Not applicable
Article 25 – Illegal transboundary movements
168. Has your country adopted domestic measures aimed at preventing and/or penalizing transboundary movements of LMOs carried out in contravention of its domestic measures to implement this Protocol?
  • Yes
169. Has your country established a strategy for detecting illegal transboundary movements of LMOs?
  • No
170. In the current reporting period, how many times has your country received information concerning cases of illegal transboundary movements of an LMO to or from territories under its jurisdiction?
  • Never
175. Here you may provide further details on the implementation of Article 25 in your country:
ES
A pesar de que en la República Bolivariana de Venezuela no existe una ley específica que prevenga y penalice los movimientos transfronterizos de OVM realizados en contravención de las medidas nacionales que rigen la aplicación del Protocolo, hay leyes indirectas que permiten tomar acciones jurídicas para penalizar tal actividad.
Article 26 – Socio-economic considerations
176. If your country has taken a decision on import, has it ever taken into account socio-economic considerations arising from the impact of the LMO on the conservation and sustainable use of biological diversity?
  • Not applicable
177. Has your country cooperated with other Parties on research and information exchange on any socio-economic impacts of LMOs?
  • Yes, to a limited extent
178. Here you may provide further details on the implementation of Article 26 in your country:
ES
En Venezuela se deben hacer estudios de impacto ambiental relacionados con OVM para la evaluación de cultivos transgénicos y animales de investigación y cría que pudieran ser empleados en el país.
Article 27 – Liability and Redress
179. Has your country signed the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress?
  • No
180. Has your country initiated steps towards ratification, acceptance or approval of the Nagoya-Kuala Lumpur Supplementary Protocol?
  • No
181. Here you may provide further details on any activities undertaken in your country towards the implementation of the Nagoya-Kuala Lumpur Supplementary Protocol on Liability and Redress:
ES
El país se encuentra haciendo reuniones de trabajo con los diferentes ministerios para evaluar la pertinencia  o no de suscribir el protocolo sumplementario de Nagoya - Kuala Lumpur sobre responsabilidad y compensación.
Article 33 – Monitoring and reporting
182. Has your country submitted the previous national reports (Interim and First National Reports)?
  • Yes
183. If your country did not submit previous reports, indicate the main challenges that hindered the submission
  • No hemos tenido obstáculos
Other information
184. Please use this field to provide any other information on issues related to national implementation of the Protocol, including any obstacles or impediments encountered.
ES
La bioseguridad ha cobrado mucha importancia en la República Bolivariana de Venezuela a medida que se ha incrementado la actividad biotecnológica en el país. Por este motivo, con financiamiento nacional se ha finalizado por completo el diseño y construcción de un Laboratorio de Referencia de Detección de OVM, y la República se encuentra trabajando actualmente en el proyecto de equipamiento y consecución de los recursos nacionales para ello. Adicionalmente, se cuenta con recursos humanos capacitados para asumir la tarea de detección de OVM, relevante para el cumplimiento normativo, y para el manejo del CIISB. Si bien estos logros son significativos en cuanto a la creación de capacidad científica-tecnológica, no están vinculados a mecanismos eficientes de coordinación ínter-institucional que consagren su contribución a la implementación del PCB. En ausencia de apoyo del GEF, el Gobierno Central, a través del Ministerio del Poder Popular para el Ambiente y el Ministerio del Poder Popular para la Ciencia y Tecnología, continuarían desarrollando capacidades institucionales y humanas, en pos del seguimiento de los OVM, pero sin ir de la mano del entrenamiento de personal de aduanas o de profesionales encargados de las evaluaciones de OVM, o de la sensibilización de los tomadores de decisión y del público en general. El desarrollo de normativas sería otra tarea que le correspondería al Gobierno Central, que ocurriría probablemente a paso lento y sin la concomitante instalación de los sistemas administrativos necesarios. Las actuaciones conjuntas entre el Estado Venezolano y un posible proyecto PNUMA-FMAM para la implementación del Marco Nacional de Bioseguridad, debe hacerse basado en una construcción colectiva, incluyendo el debate público con los sectores interesados en la aplicación de la biotecnología. Esto permitirá sustentar la toma de decisiones en conocimientos científicos, valores humanos y principios bioéticos. El apoyo del GEF, podría ayudar eficazmente a movilizar suficientes sectores y lograr acciones mancomunadas para asegurar un adecuado nivel de protección en el uso, manejo, transferencia y utilización segura de los organismos resultantes de la aplicación de la biotecnología moderna. Por lo anterior, los participantes de las diferentes instituciones que tienen relación con la bioseguridad en el país y que asistieron a los talleres efectuados para el desarrollo de este segundo informe de país señalaron que se requiere de cooperación para la implementación del Marco Nacional de Bioseguridad en Venezuela.   
Comments on reporting format
185. Please use this field to provide any other information on difficulties that you have encountered in filling in this report.
ES
Existe cierta dificultad en el empleo del formato, sobretodo porque hay espacios muy limitados para responder las preguntas, ejemplo, Articulo 2 disposiciones generales.
Survey on indicators of the Strategic Plan (2014)
In decision BS-VI/15, Parties requested the Executive Secretary to conduct a dedicated survey to gather information corresponding to indicators in the Strategic Plan that could not be obtained from the second national reports or through other existing mechanisms.

The answers to the survey are displayed below.
When did your national biosafety framework become operational?
indicator 1.1.1
  • 2005
Survey 4. How many biosafety short-term training programmes and/or academic courses are offered annually in your country?
indicator 1.2.3
  • 1 per year or more
Survey 5. Does your country have in place a functional national mechanism for coordinating biosafety capacity-building initiatives?
indicator 1.2.4
  • Yes
Survey 6. How much additional funding (in the equivalent of US dollars) has your country mobilized in the last four years to support implementation of the Biosafety Protocol, beyond the regular national budgetary allocation?
indicator 1.2.5
  • 5,000 USD or more
Survey 7. Does your country have predictable and reliable funding for building capacity for the effective implementation of the Protocol?
indicator 1.2.6
  • Yes
Survey 8. How many LMO-related collaborative bilateral/multilateral arrangements has your country established with other Parties/non-Parties?
indicator 1.2.8
  • One or more
Survey 9. Has your country adopted or used any guidance documents for the purpose of conducting risk assessment and/or risk management?
indicator 1.3.1.1
Survey 9.a) Risk assessment
  • No
Survey 9.b) Risk management
  • No
Survey 10. Has your country adopted or used any guidance documents for the purpose of evaluating risk assessment reports submitted by notifiers?
indicator 1.3.1.2
  • No
Here you may provide further details
ES
Hasta ahora no hay solicitudes
Survey 11. Has your country adopted any common approaches to risk assessment with other countries?
indicator 1.3.2
  • No
Survey 12. Has your country ever conducted a risk assessment of an LMO?
indicator 1.3.3
  • No
Survey 13. Does your country have the capacity to identify, assess and/or monitor living modified organisms or specific traits that may have adverse effects on the conservation and sustainable use of biological diversity, taking into account risks to human health?
indicator 1.4.2
Survey 13.a) Identify
  • Yes
Survey 13.b) Assess
  • Yes
Survey 13.c) Monitor
  • Yes
Here you may provide further details
ES
Pero a pequeña escala, por ello pretendemos trabajar en la implementacion del marco nacional de bioseguridad, a traves de un proyecto PNUMA-GEF
Survey 14. Does your country have available any guidance for the purpose of ensuring the safe handling, transport, and packaging of living modified organisms?
indicator 1.6.4
  • No
Here you may provide further details
ES
Por ello pretendemos deseamos implementar el marco nacional de bioseguridad, a traves de un proyecto PNUMA-GEF
Survey 15. Does your country have any specific approaches or requirements that facilitate how socio-economic considerations should be taken into account in LMO decision making?
indicator 1.7.2
  • No
Survey 16. How many peer-reviewed published materials has your country used for the purpose of elaborating or determining national actions with regard to socio-economic considerations?
indicator 1.7.1
  • One or more
Survey 17. What is your country's experience, if any, in taking socio-economic considerations into account in LMO decision making?
indicator 1.7.3
ES
Posee poca experiencia
Survey 18. Does your country have the capacity to take appropriate measures in the event that an LMO is unintentionally released?
indicator 1.8.3
  • Yes
Survey 19. How many people in your country have been trained in risk assessment, monitoring, management and control of LMOs?
indicator 2.2.3
Survey 19.a) Risk assessment
  • One or more
Survey 19.b) Monitoring
  • One or more
Survey 19.c) Management / Control
  • One or more
Survey 20. Does your country have the infrastructure (e.g. laboratory facilities) for monitoring or managing LMOs?
indicator 2.2.4
  • Yes
Survey 21. Is your country using training material and/or technical guidance for training in risk assessment and risk management of LMOs?
indicator 2.2.5
  • Yes
Survey 22. Are the available training materials and technical guidance on risk assessment and risk management of LMOs sufficient and effective?
indicator 2.2.6
Survey 22.a) Sufficient
  • Yes
Survey 22.b) Effective
  • Yes
Survey 23. How many customs officers in your country have received training in the identification of LMOs?
indicator 2.3.1
  • 10 or more
Survey 24. How many laboratory personnel in your country have received training in detection of LMOs?
indicator 2.3.1
  • 10 or more
Survey 25. Does your country have reliable access to laboratory facilities for the detection of LMOs?
indicator 2.3.2
  • Yes
Survey 26. How many laboratories in your country are certified for LMO detection?
indicator 2.3.3
  • One or more
Survey 27. How many of the certified laboratories in the previous question are operational?
indicator 2.3.4
  • One or more
Survey 28. Has your country received any financial and/or technical assistance for capacity-building in the area of liability and redress relating to living modified organisms?
indicator 2.4.1
  • No
Survey 29. Does your country have administrative or legal instrument that provide for response measures for damage to biodiversity resulting from living modified organisms?
indicator 2.4.2
  • Yes
Here you may provide further details
ES
Existe una Ley, pero se debe desarrollar el reglamento de esa Ley
Survey 30. Has your country informed the public about existing modalities for public participation in the decision-making process regarding living modified organisms?
indicator 2.5.2
  • Yes
Survey 31. If you answered yes to the previous question, please indicate the modalities used to inform the public?
indicator 2.5.2
  • National website
Survey 32. If you indicated multiple modalities for public participation in the question above, which one was most used?
indicator 2.5.2
  • National website
Survey 33. How many academic institutions in your country are offering biosafety education and training courses and programmes?
indicator 2.7.1
  • One or more
Survey 34. How many biosafety training materials and/or online modules are available in your country?
indicator 2.7.2
  • One or more
Survey 35. Does your country have in place a monitoring and/or an enforcement system?
indicator 3.1.6
Survey 35.a) Monitoring system
  • Yes
Survey 35.b) Enforcement system
  • Yes
Survey 36. Please indicate the number of regional, national and international events organized in relation to biosafety (e.g. seminars, workshops, press conferences, educational events, etc.,) in the last 2 years.
indicator 4.3.1
  • 10 or more
Survey 37. Please indicate the number of biosafety related publications that has been made available in your country in the last year.
indicator 4.3.2
  • 10 or more
Survey 38. If biosafety related publications were made available (see question above), please indicate which modalities were preferred.
indicator 4.3.2
  • National Libraries
Survey 39. How many collaborative initiatives (including joint activities) on the Cartagena Protocol and other Conventions and processes has your government established in the last 4 years?
indicator 5.2.1
  • One or more
Survey 40. Does your country have any awareness and outreach programmes on biosafety?
indicator 5.3.1
  • Yes
Survey 41. If you answered yes to the question above, please indicate what entity is responsible for carrying out the programmes and/or services and at which level the programmes take place.
indicator 5.3.1
E.g. local, national, etc.,
ES
Universidad Central de Venezuela. Escuela Socialista de Agricultura Tropical. Instituto de Estudios Avanzados (IDEA)
Survey 42. Has your country designed and/or implemented an outreach/communication strategy on biosafety?
indicator 5.3.2
  • Yes
Survey 43. Please indicate the number of educational materials on biosafety that are available and accessible to the public.
indicator 5.3.4
  • One or more